Apolipoprotein e genotype and cognition in bipolar disorder

CNS Neuroscience and Therapeutics

Volumn 16, Issue 5, 2010, Pages 316-321

  De Souza, Márcio Gerhardt Soeiro ^a   Bio, Danielle Soares ^a   Dias, Vasco Videira ^b   Prado, Carolina Martins Do ^a   Campos, Rodolfo Nunes ^a   Costa, Luis Felipe De Oliveira ^a   Moreno, Doris Hupfeld ^a   Ojopi, Elida Benquique ^a   Gattaz, Wagner Farid ^a   Moreno, Ricardo Alberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

Apolipoprotein E; Bipolar depression; Bipolar disorder; Cognition; Executive function; Mania

Indexed keywords

APOLIPOPROTEIN E; GENOMIC DNA;

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITION; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; MALE; MANIA; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; RACE DIFFERENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE; ADOLESCENT; COGNITIVE DEFECT; GENE FREQUENCY; GENETICS; NUCLEOTIDE SEQUENCE;

ADOLESCENT; ADULT; APOLIPOPROTEINS E; BIPOLAR DISORDER; COGNITION DISORDERS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; YOUNG ADULT;

EID: 77956400198     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2010.00153.x     Document Type: Article

References (46)

1. de Geus EJ, Wright MJ, Martin NG, Boomsma DI. Genetics of brain function and cognition. Behav Genet 2001 31 : 489 495.
2. Zannis VI, Kardassis D, Zannis EE. Genetic mutations affecting human lipoproteins, their receptors, and their enzymes. Adv Hum Genet 1993 21 : 145 319.
3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993 261 : 921 923.
4. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein *4 allele distributions in late onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993 342 : 710 711.
5. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier Sl. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993 342 : 697 699.
6. Meyer MR, Tschanz JT, Norton MC, et al. ApoE genotypes predict when - not whether - one is predisposed to develop Alzheimer disease. Nat Genet 1998 19 : 321 322.
7. Gomez IT, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol 1996 39 : 62 70.
8. Bookheimer SY, Strojwas MH, Cohen MS, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000 343 : 450 456.
9. Mauch DHK, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001 294 : 1354 1357.
10. Small BJ, Rosnick CB, Fratiglioni L, Backman L. Apolipoprotein E and cognitive performance: A meta-analysis. Psychol Aging 2004 19 : 592 600.
11. Staehelin HB, Perrig-Chiello P, Mitrache C, Miserez AR, Perrig WJ. Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta Neurol Scand 1999 100 : 53 60.
12. Corder EH, Lannfelt L, Viitanen M, Corder LS, Manton KG, Winblad B. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have goodcognition. Arch Neurol 1996 53 : 418 422.
13. Lahiri DK, Sambamurti K, Bennett DA. Apolipoprotein gene and its interaction with the environmentally driven risk factors: Molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiol Aging 2004 25 : 651 660.
14. Wisdom NM, Callahan JL, Hawkins KA. The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Available at http://www.neurobiologyofaging.org/article/S0197-4580(09)00038-4/pdf. Accessed March 14, 2009.
15. Dean B, Digney A, Sundram S, Thomas E, Scarr E. Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder. Psychiatry Res 2008 158 : 75 8.
16. Kessing LV, Jørgensen OS. Apolipoprotein E-epsilon 4 frequency in affective disorder. Biol Psychiatry 1999 45 : 430 434.
17. Krishnan KRM, Tupler LA. Apolipoprotein E-ε4 allele frequency in late-onset depression. Biol Psychiatry 1997 41 : 912- 14.
18. Zubenko GS, Henderson R, Stiffler JS, Stabler S, Rosen J, Kaplan BB. Association of the APOE ε4 allele with clinical subtypes of late life depression. Biol Psychiatry 1996 40 : 1008 1016.
19. Kessing LV, Dam H, Jørgensen OS, Bolwig TG. Cognitive impairment in affective disorders. Relation to illness characteristics. Nord J Psychiatry 1996 50 : 305 316.
20. Krishnan KRM, Tupler LA, Ritchie JC Jr., et al. Apolipoprotein E-ε4 frequency in geriatric depression. Biol Psychiatry 1996 40 : 69 71.
21. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003 160 636 645.
22. Martinez-Arán A, Vieta E, Colom F, et al. Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom 2000 69 : 2 18.
23. Rocca CCA and Lafer B. Neuropsychological disturbances in bipolar disorder. Rev Bras Psiq 2006 28 : 226 237.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., Washington, DC : American Psychiatric Press, 1994.
25. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured clinical interview for DSM-IV (SCID). Washington, DC, USA : APA Press, 1997.
26. Del-Ben CM, Vilela JAA, Crippa JÁ, Hallak JEC, Labate CM, Zuardi AW. Confiabilidade da "Entrevista Clínica Estruturada para o DSM IV - Versão Clínica" traduzida para o português. Rev Bras Psiq 2001 23 : 156 159.
27. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for Mania: Reliability, validity and sensitivity. Br J Psychiatry 1978 133 : 429 435.
28. Hamilton MA. Rating scale for depression. J Neurol Neurosurg Psychiatry 1960 23 : 56 62.
29. Wechsler D. Wechsler memory scale - revised. New York : Psychological Corp, 1987.
30. Wechsler D. Wechsler adult intelligence scale, 3rd ed. San Antonio, Texas : The Psychological Corporation, 1997.
31. Reitan RM. Validity of the Trailmaking Test as an indication of organic brain damage. Percept Motor Skills 1958 8 : 271 276.
32. Spreen O, Strauss E. A compendium of neuropsychological tests. New York : Oxford University Press, 1998.
33. Heaton RK. Wisconsin card sorting test manual. Odessa, Florida : Psychological Assessment Resources, INC, 1981.
34. Wechsler D. Wechsler abbreviated scale of intelligence (WASI). San Antonio : The Psychological Corporation/Harcourt Brace & Company, 1999.
35. Laitinen J, Samarut J, Holtta E. A nontoxic and versatile protein salting-out method for isolation of DNA. Bio Techniques 1994 17 : 316 322. (Pubitemid 2125267)
36. Reilly SL, Ferrell RE, Sing CF. The gender-specific Apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III. Correlations and covariances. Am J Hum Genet 1994 55 : 1001 1018.
37. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991 151 : 75 78.
38. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996 58 : 803 811.
39. Barrett-Conner E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993 269 : 2637 2641.
40. Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994 83 : 979 983.
41. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994 42 : 919 922.
42. Robinson JL, Bearden CE, Monkul ES, et al. Fronto-temporal dysregulation in remitted bipolar patients: An fMRI delayed-non-match-to-sample (DNMS) study. Bipolar Disord 2009 11 : 351 360.
43. Wilson RS, Schneider JA, Barnes LL, Beckett LA, Aggarwal NT, Cochran EJ. Apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol 2002 59 : 1154 1160.
44. Corder EH, Ghebremedhin E, Thal DR, Ohm TG, Braak H. Alzheimer pathogenesis for men and women. Alzheimer Dis Res J 2008 2 : 39 52.
45. Schachter F, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994 6 : 29 32.
46. Bellivier F, Laplanche JL, Schurhoff F, et al. Apolipoprotein E gene polymorphism in early and late onset bipolar patients. Neurosci Lett 1997 233 : 45 48.